Key facts
- This page summarizes Dr. Jon Hayashida's Form 4 filing for STAAR SURGICAL CO (STAA).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 12 May 2021, 17:05.
Dr. Jon Hayashida - 10 May 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)
- Reporting relationship
- VP, Global Clinical, Medical
- Issuer ticker
- STAA
- Reported as of
- 10 May 2021
- Net transaction value
- -$1,036,156
- Reporting owner signature
- /s/ Samuel Gesten as attorney-in-fact for Dr. Jon Hayashida
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Dr. Jon Hayashida filed Form 4 for STAAR SURGICAL CO (STAA) on 12 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$1,036,156.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
STAA
transaction
Common Stock
Sale
- Transaction value
- $168,922
- Shares
- -1,349
- Change %
- -14%
- Price
- $125.22
- Shares after
- 8,342
- Date
- 10 May 2021
- Ownership
- Direct
- Footnotes
- F1
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- $116,280
- Shares
- +7,200
- Change %
- +86%
- Price
- $16.15
- Shares after
- 15,542
- Date
- 10 May 2021
- Ownership
- Direct
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- $75,513
- Shares
- +2,534
- Change %
- +16%
- Price
- $29.80
- Shares after
- 18,076
- Date
- 10 May 2021
- Ownership
- Direct
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- $124,563
- Shares
- +3,462
- Change %
- +19%
- Price
- $35.98
- Shares after
- 21,538
- Date
- 10 May 2021
- Ownership
- Direct
STAA
transaction
Common Stock
Options Exercise
- Transaction value
- $152,048
- Shares
- +5,523
- Change %
- +26%
- Price
- $27.53
- Shares after
- 27,061
- Date
- 10 May 2021
- Ownership
- Direct
STAA
transaction
Common Stock
Sale
- Transaction value
- $1,335,639
- Shares
- -10,760
- Change %
- -40%
- Price
- $124.13
- Shares after
- 16,301
- Date
- 10 May 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
STAA
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -7,200
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,200
- Exercise price
- $16.15
- Footnotes
- F3
STAA
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -2,534
- Change %
- -77%
- Price
- $0.000000
- Shares after
- 750
- Date
- 10 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,534
- Exercise price
- $29.80
- Footnotes
- F4
STAA
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -3,462
- Change %
- -29%
- Price
- $0.000000
- Shares after
- 8,564
- Date
- 10 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,462
- Exercise price
- $35.98
- Footnotes
- F5
STAA
transaction
Derivative
Common Stock Options
Options Exercise
- Transaction value
- $0
- Shares
- -5,523
- Change %
- -36%
- Price
- $0.000000
- Shares after
- 9,774
- Date
- 10 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,523
- Exercise price
- $27.53
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.02 to $135.64, inclusive.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.85 to $135.64, inclusive.
Footnote F3
The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2028.
Footnote F4
The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2028.
Footnote F5
The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
Footnote F6
The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.